|
Feb 18
|
SalMar – Satisfactory results and good biological development towards the end of the quarter
|
|
Feb 12
|
SalMar - Invitation to presentation of the fourth quarter 2024 results
|
|
Jun 12
|
SalMar - Extension of Commercial Paper
|
|
Dec 19
|
SalMar - 2023 share-based incentive scheme for senior executives and key personnel
|
|
Sep 29
|
SalMar – Notice of extraordinary general meeting regarding capital reduction following completion of intra-group merger
|